Oragenics, Inc.
OGEN
$0.183
$0.0084.57%
AMEX
| 12/31/2024 | 09/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | 89.44% | -3.07% | |||
| Gross Profit | -89.44% | 3.07% | |||
| SG&A Expenses | 8.47% | 11.36% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 37.67% | 5.69% | |||
| Operating Income | -37.67% | -5.69% | |||
| Income Before Tax | -35.98% | -6.85% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -35.98% | -6.85% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -35.98% | -6.85% | |||
| EBIT | -37.67% | -5.69% | |||
| EBITDA | -37.78% | -5.71% | |||
| EPS Basic | 25.50% | 25.87% | |||
| Normalized Basic EPS | 25.49% | 25.87% | |||
| EPS Diluted | 25.50% | 25.87% | |||
| Normalized Diluted EPS | 25.49% | 25.87% | |||
| Average Basic Shares Outstanding | 82.54% | 44.14% | |||
| Average Diluted Shares Outstanding | 82.54% | 44.14% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||